The coronavirus continues to dominate headlines and impacts every aspect of our daily lives. In this 20-minute webinar, Clinical Pharmacy Specialist Kate Dzintars, PharmD, BCPS-AQID, will help you navigate through this new normal and provide some guidance on how your Antimicrobial Stewardship Program could be severely impacted.
In this webinar, Dr. Dzintars will:
* Evaluate the available data on the rate of bacterial co-infection and secondary infection in patients presenting with COVID-19
* Discuss antibiotic (over)use in patients presenting with COVID-19
* Identify practices to complement antimicrobial stewardship programs during the COVID-19 pandemic
If you are interested in more information about the Johns Hopkins ABX Guide or Unbound’s Local Antimicrobial Stewardship Solution, visit:
About the speaker:
Dr. Dzintars obtained her Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy. She completed her pharmacy practice residency at the University Health System and a specialty residency in Infectious Diseases at the South Texas Veterans Health Care System, both in conjunction with The University of Texas Health Science Center, San Antonio, TX. She is currently a clinical pharmacy specialist in Infectious Diseases and Antimicrobial Stewardship at The Johns Hopkins Hospital. Dr. Dzintars is Chair of the Infectious Diseases Specialty Council for the Board of Pharmaceutical Specialties and is the past Chair of the Antibiotic Subcommittee for the Maryland Society of Health-system Pharmacists. Her current professional interests include antimicrobial stewardship, antifungal therapy, and Gram-negative resistance.
